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Abstract   
Introduction: The major histocompatibility complex (MHC) is a group of cell surface 
proteins that are essential for recognizing foreign molecules in human and other mammals. 
The physiologic function of MHC molecules is the presentation of peptides to T cells. In this 
study, we evaluated the purification of a class II MHC molecule (HLA-DR) from a human 
Burkitt′s lymphoma cell line; Daudi. 
Materials and methods: We described a simple procedure for purifying human HLA 
molecules from the cells lysate. As a representative model, HLA-DR was purified from 
Daudi cell line. The cell membrane was solubilized by a buffer contained NP-40 detergent. 
Subsequently, the isolation of the membrane antigen was carried out by affinity 
chromatography method using mouse anti-human HLA-DR monoclonal antibody. The size 
and the specificity of the purified antigen were determined by Bradford and ELISA methods, 
respectively. 
Results: The purified HLA antigen was obtained in approximately 20-30 micrograms in each 
run of chromatography. Additionally, ELISA method demonstrated the HLA-DR specificity 
of the purified protein.   
Conclusion: The results indicated that affinity purification of HLA-DR antigen by means of 
specific monoclonal antibody is a simple and fast procedure for obtaining the purified 
antigen. 
Keywords: HLA-DR, Affinity chromatography, ELISA 
Introduction  
Major histocompatibility complex (MHC) 
encodes protein molecules that are highly 
polymorphic surface glycoproteins. These 
molecules are involved in immune 
recognition (1). Most nucleated cells 
constitutively express MHC class I, 
whereas MHC class II is restricted to 
antigen presenting cells (APCs) such as 
dendritic cells, macrophages and B cells. 
The class I MHC molecule consists of two 
non-covalently associated chains; a 44,000 
Da transmembrane α chain, and a 14,000 
Da β2-microglobulin component. The gene 
products of the class I locus are HLA-A, -
B, and -C. The class II MHC molecule has 
two non-covalently associated 
transmembrane chains; α chain of 34,000 
Da and β chain of 29,000 Da (2). The gene 
products of the class II locus are HLA-D. 
Both class I and class II MHC proteins are 
strongly associated with a broad spectrum 
of peptides which are presented to T cell, 
via interaction with the T cell receptor     
(1, 3). Of the three allelic HLA-D forms 
HLA-DR, HLA-DP, and HLA-DQ, the 
major product is HLA-DR. The HLA-DR 
region of the MHC localizes in the short 
arm of the chromosome 6 and its 
importance in immunological reactions has 
been demonstrated (4-7). The most 
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commonly used procedure for purification 
of MHC molecules is based on affinity 
chromatography originally developed by 
Parham (1976) and Gorga et al. (1). 
Affinity chromatography, a highly 
selective separation technique, is a type of 
adsorption chromatography where the 
target molecule is reversibly adsorbed by a 
ligand immobilized on an insoluble 
support. The ligand is selected with respect 
to its affinity for a biomolecule, such as 
the affinity of an antibody to its antigen or 
that of an antigen to its antibody (8-10). 
Here an optimized affinity 
chromatography protocol was used to 
isolate and purify the HLA-DR antigen 
from the membrane of an immortalized B 
cell line. This cell line doesn't express 
HLA class I molecules. The cell lysate was 
prepared and an affinity chromatography 
was established.  
Materials and methods 
Daudi Cell line : Human Burkitt′s 
lymphoma cell line; Daudi was purchased 
from National Cell Bank of Iran in Pasteur 
Institute. Cells were grown in RPMI 1640 
(Gibco, Germany) supplemented with 10% 
fetal bovine serum (FBS) (Gibco, 
Germany), 1.0% L-glutamine (Merck, 
Germany), 100 U/ml penicillin (Sigma, 
USA) and 100 µg/ml streptomycin (Sigma, 
USA). Cells were pelleted, washed with 
phosphate-buffered saline (PBS) and kept 
frozen at -70  until the solubilization of 
lipid bilayers.  
Solubilization of the cell membrane 
proteins : For the preparation of the 
solubilized cell membrane antigens, cells 
were suspended in 1 ml lysis buffer 
containing; 25 mM Tris-HCL (Merck, 
Germany), 150 mM NaCL, 10 mM EDTA, 
1.0% NP-40, pH 7.5 and 1 mM 
phenylmethylsulfonyl fluoride (PMSF; 
Sigma, USA) with vigorous vortexing. To 
remove insoluble cellular debris, the lysate 
was centrifuged at 1000 g for 10 min. The 
supernatant was collected and dialyzed 
against three changes of PBS buffer over 
24 hours. 
Immobilization of antibody on cyanogen 
bromide-activated Sepharose 4B: The 
monoclonal antibody mouse anti-human 
HLA-DR (Origene Technologies, USA) 
was coupled to CNBr-activated Sepharose 
4B (Sigma, USA), according to the 
manufacturer's instructions 
Purification by affinity chromatography 
column: The supernatant of the cell lysate 
was passed through the HLA-DR affinity 
column, which was equilibrated with PBS. 
The HLA-DR antigen was eluted from the 
column by the elution buffer (0.2 M 
glycine, pH 2.8). The eluted protein was 
immediately neutralized with 2M Tris-
buffer pH 8.0. Protein fractions were 
collected and evaluated for the protein 
existence by reading the absorption at 280 
nm. After condensing the eluted protein, 
the protein concentration was measured by 
Bradford method using different 
concentrations of bovine serum albumin 
(BSA) (Merck, Germany) as the standard 
protein. 
The specificity of the purified antigen: 
The specificity of HLA-DR antigen was 
determined by enzyme-linked 
immunosorbent assay (ELISA) method. 
Fifty microliters of the purified antigen 
(5µg/ml) was coated in the wells of a 
polystyrene microtiter plate (Nunc, 
Denmark) at 4 . The wells 
were blocked with 2% BSA for 3 hours at 
room temperature. Mouse anti-human 
HLA-DR antibody was added and the 
wells were incubated for 1 hour at room 
temperature. Then peroxidase-conjugated 
anti-mouse IgG (Fc specific) antibody 
(Sigma-Aldrich) was added. Between each 
step the wells were washed three times 
with PBS contained 0.06% Tween 20 
(Sigma, USA) to remove the unbound 
molecules. TMB substrate solution 
(Trinity Biotech, USA) was added. 
Finally, after addition of the stop solution, 
the absorption was read at 450 nm. 
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Results  
The reaction of the purified antigen with 
HLA-DR-specific antibody was shown. 
On the other hand negative results were 
observed for the wells with phosphate 
buffer (PBS) or wells coated with human 
chorionic gonadotropin (HCG) as an 
unrelated antigen. The results 
demonstrated that the purified antigen was 
HLA-DR (Figure 1). ELISA results for 3 
lots of HLA-DR molecules was shown in 
Figure 1. 
 
 
 
 
 
Figure 1. The specificity of the purified antigen was demonstrated using ELISA method. The reaction of the 
purified antigen with HLA-DR-specific antibody was shown. Negative results were obtained for PBS and HCG 
as an unrelated antigen. The results demonstrated that the purified antigen was HLA-DR. In this figure; 1, 2 and 
3 refers to the optical densities of three lots of HLA-DR antigens obtained by affinity chromatography. 
Discussion 
Several protocols have been developed for 
the purification of different proteins. These 
protocols combine different protein 
purification techniques, such as ion 
exchange, gel filtration and affinity 
chromatography. Affinity chromatography 
by means of specific monoclonal 
antibodies can simplify the isolation of the 
protein of interest (11-14). The aim of this 
study was to purify HLA-DR antigen 
using affinity chromatography under the 
proper conditions that do not disturb the 
structural integrity of the protein. Daudi 
cell line was selected because it does not 
express HLA class I molecules but express 
HLA class II antigens (15). The detergent 
NP-40 at the concentration of 1.0 % was 
not toxic to the target cells (16, 17). The 
procedure described here can be suitable 
for obtaining HLA antigens from each cell 
type. Finally, purified HLA-DR antigen 
was characterized by ELISA method using 
monoclonal antibody specific for HLA-
DR. Our study was correlated with 
Andrews and co-workers that used 
immunoaffinity chromatography to purify 
HLA-DR antigens. Although, they 
analyzed the purity of the protein using 
SDS-PAGE, they didn’t analyze the 
specificity of the purified protein. We 
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developed a simple and fast procedure to 
obtain a pure preparation of membrane 
proteins from each cell line. The simplicity 
of this method with minimal amount of the 
antibodies makes this method valuable. 
The purified protein can be used as an 
immunogen or any immunologic studies.  
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